Zhenzhong Zhang Selected Research

Drug Carriers

7/2022	Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade.
1/2022	Combining Fruquintinib and Doxorubicin in Size-Converted Nano-Drug Carriers for Tumor Therapy.
8/2019	In Situ Autophagy Disruption Generator for Cancer Theranostics.
10/2018	Preparation and Evaluation of Multifunctional Autofluorescent Magnetic Nanoparticle-Based Drug Delivery Systems Against Mammary Cancer.
1/2018	Multi-functional magnetic nanoparticles as an effective drug carrier for the controlled anti-tumor treatment.
1/2016	A novel redox-sensitive system based on single-walled carbon nanotubes for chemo-photothermal therapy and magnetic resonance imaging.
3/2015	Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy.
1/2015	Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles.
7/2014	A fullerene-based multi-functional nanoplatform for cancer theranostic applications.
1/2014	In vitro and in vivo evaluation of antitumor drug-loaded aptamer targeted single-walled carbon nanotubes system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenzhong Zhang Research Topics

Disease

143	Neoplasms (Cancer) 07/2022 - 11/2008
13	Breast Neoplasms (Breast Cancer) 12/2021 - 02/2012
8	Hyperthermia 01/2018 - 04/2013
7	Neoplasm Metastasis (Metastasis) 07/2022 - 03/2015
6	Hypoxia (Hypoxemia) 01/2021 - 10/2017
5	Carcinoma (Carcinomatosis) 11/2019 - 02/2012
4	Melanoma (Melanoma, Malignant) 06/2022 - 01/2020
4	Inflammation (Inflammations) 01/2022 - 01/2017
3	Thrombosis (Thrombus) 01/2022 - 01/2020
3	Ischemic Stroke 01/2022 - 01/2020
3	Glioma (Gliomas) 11/2015 - 02/2012
2	Reperfusion Injury 01/2022 - 01/2020
2	Bites and Stings (Sting) 01/2022 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 05/2018
2	Stroke (Strokes) 01/2022 - 01/2020
2	Infarction (Infarctions) 01/2022 - 01/2020
2	Starvation 01/2022 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2016

Drug/Important Bio-Agent (IBA)

44	Pharmaceutical PreparationsIBA 07/2021 - 01/2010
17	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 12/2011
16	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 04/2013
15	Peptides (Polypeptides)IBA 12/2021 - 11/2008
14	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 01/2013
14	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2021 - 01/2013
13	Liposomes (Liposome)IBA 01/2021 - 01/2010
13	Carbon Nanotubes (Carbon Nanotube)IBA 01/2017 - 01/2011
12	Photosensitizing Agents (Photosensitizers)IBA 12/2021 - 07/2014
10	Drug CarriersIBA 07/2022 - 01/2014
10	2-MethoxyestradiolIBA 01/2021 - 01/2010
9	Therapeutic UsesIBA 01/2022 - 08/2011
9	Proteins (Proteins, Gene)FDA Link 08/2021 - 03/2015
9	GoldIBA 10/2019 - 03/2015
9	Contrast MediaIBA 08/2019 - 07/2014
8	Biological ProductsIBA 01/2022 - 09/2018
8	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 11/2008
8	Small Interfering RNA (siRNA)IBA 05/2018 - 08/2011
8	Folic Acid (Vitamin M)FDA LinkGeneric 12/2017 - 01/2013
7	Oxygen (Dioxygen)IBA 06/2021 - 10/2015
7	graphene oxideIBA 10/2020 - 07/2014
7	NGR peptideIBA 01/2020 - 01/2011
6	PolyethyleneimineIBA 08/2021 - 11/2008
6	AcidsIBA 08/2021 - 01/2016
6	Mercaptoethanol (2 Mercaptoethanol)IBA 12/2017 - 02/2012
6	SolutionsIBA 01/2017 - 04/2012
6	FullerenesIBA 10/2016 - 01/2013
5	CopperIBA 07/2022 - 01/2016
5	HydrogelsIBA 03/2016 - 12/2011
4	EnzymesIBA 06/2022 - 01/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2015
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 11/2008
4	MicellesIBA 01/2022 - 10/2014
4	Glutathione (Reduced Glutathione)IBA 01/2021 - 01/2016
4	fullerene C60IBA 02/2020 - 07/2014
4	LigandsIBA 09/2018 - 11/2008
4	Docetaxel (Taxotere)FDA Link 03/2016 - 01/2011
3	Metal-Organic FrameworksIBA 07/2022 - 07/2021
3	ProdrugsIBA 07/2022 - 12/2014
3	Angiopep-2IBA 12/2021 - 11/2015
3	artemisinin (artemisinine)IBA 05/2021 - 01/2015
3	manganese oxide (hausmannite)IBA 05/2021 - 01/2016
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2020 - 01/2017
3	AntigensIBA 01/2020 - 10/2019
3	ManganeseIBA 01/2020 - 01/2016
3	Biocompatible Materials (Biomaterials)IBA 11/2019 - 01/2015
3	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2019 - 01/2015
3	LipidsIBA 12/2017 - 05/2010
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2017 - 07/2014
3	IonsIBA 10/2017 - 01/2015
3	cupric sulfide (CuS)IBA 06/2017 - 01/2017
3	Transferrin (beta 2 Transferrin)IBA 01/2017 - 01/2015
3	manganese dioxideIBA 01/2017 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 01/2022
2	Arginine (L-Arginine)FDA Link 07/2022 - 11/2008
2	Catalytic DNA (Deoxyribozyme)IBA 01/2022 - 12/2021
2	Free RadicalsIBA 01/2022 - 01/2020
2	Thrombin FDA Link 11/2021 - 01/2020
2	PolymersIBA 08/2021 - 12/2019
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 07/2021 - 01/2019
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 11/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 12/2019
2	MicroRNAs (MicroRNA)IBA 10/2020 - 12/2019
2	RNA (Ribonucleic Acid)IBA 02/2020 - 12/2019
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2020 - 09/2019
2	NanogelsIBA 02/2020 - 01/2016
2	phytochlorinIBA 01/2020 - 10/2019
2	DisulfidesIBA 12/2019 - 11/2019
2	titanium dioxide (Titania)FDA Link 09/2019 - 08/2017

Therapy/Procedure

77	Therapeutics 07/2022 - 11/2008
36	Drug Therapy (Chemotherapy) 07/2022 - 10/2011
23	Precision Medicine 08/2019 - 12/2013
19	Photochemotherapy (Photodynamic Therapy) 12/2021 - 01/2013
18	Lasers (Laser) 01/2021 - 04/2013
16	Photothermal Therapy 09/2018 - 01/2013
9	Phototherapy (Light Therapy) 01/2018 - 10/2014
8	Immunotherapy 06/2022 - 01/2018
5	Induced Hyperthermia (Thermotherapy) 01/2022 - 08/2015
5	Aftercare (After-Treatment) 01/2022 - 07/2018
4	Intravenous Administration 08/2011 - 05/2010
3	Intravenous Injections 07/2018 - 01/2010
3	Injections 02/2015 - 12/2011